Mankind Pharma Ltd

NSE: MANKIND BSE: 543904

₹2480

(1.73%)

Tue, 22 Sept 2026, 06:17 pm

MTF 5xInvest in Mankind Pharma Ltd with 5x Leverage Buy with MTF

Market Cap (in Cr)100363.77

PE Ratio50.18

Dividend0.04

Health Technology

Pharmaceuticals: Major

24.5K

Mankind Pharma News

Mankind Pharma appoints Anish Bafna as independent director

Mankind Pharma shareholders approved the appointment of Anish Vanraj Bafna as an independent director via postal ballot. The resolution passed with 99.96% support, with promoters casting all votes in favor.

17 Sept 2026

companies

Mankind Pharma gets ESG rating of 68.21 for FY26

Mankind Pharma has received an ESG rating of 68.21 from Niche99, placing it in the Leader category for FY26, reflecting its sustainability performance assessment.

15 Sept 2026

companies

Mankind Pharma to attend Sep investor conferences

Mankind Pharma management will participate in three investor conferences in September 2026, including events hosted by Jefferies and J.P. Morgan.

11 Sept 2026

companies

Mankind Pharma signs exclusive insulin licensing deal

Mankind Pharma has signed an exclusive licensing agreement for Insulin Degludec and the Insulin Degludec + Aspart combination in India, expanding its diabetes portfolio.

20 Aug 2026

companies

Mankind Pharma Q1FY26: Profit rises 34% YoY to ₹574 crore

Mankind Pharma reported a 34% YoY rise in consolidated net profit to ₹574.09 crore for Q1FY26, driven by 13% revenue growth. The Board also approved a ₹150 crore corporate guarantee for subsidiary BSV.

30 Jul 2026

companies

Showing 1–5 of 98

Rows per page:

Market Current News

US imposes visa curbs on 32 Prince Group TCO-linked individuals

The US State Department has imposed visa restrictions on 32 individuals linked to the Prince Group transnational criminal organisation, signalling a firm enforcement stance.

21 Sept 2026

global

Unitec Fibres IPO DRHP: Key Dates & Risks

Unitec Fibres files DRHP for ₹31 Cr fresh issue to repay debt. IPO opens Sep 23, 2026. Key risks include regulatory lapses and single-product dependency.

21 Sept 2026

ipo

Liqvd Digital India IPO DRHP: ₹26.16 Cr Fresh Issue

Liqvd Digital India files DRHP for ₹26.16 crore fresh issue. The digital marketing agency reports FY26 revenue of ₹60.24 crore and plans to complete AdLift acquisition.

21 Sept 2026

ipo

Pooja Logistics IPO DRHP: ₹33.97 Cr for Fleet Expansion

Pooja Logistics files DRHP for SME IPO opening Sep 23, 2026. Revenue hit ₹165.70 Cr in FY26. Funds to buy 92 new refrigerated trucks. GST demand risk noted.

21 Sept 2026

ipo

Coreintegra IPO DRHP: ₹18.01 Cr Fresh Issue

Coreintegra Consulting Services files DRHP for ₹18.01 crore fresh issue. HR solutions provider reports FY26 revenue of ₹515.15 crore with 18.58% CAGR. IPO opens Sep 23.

21 Sept 2026

ipo

Showing 1–5 of 94320

Rows per page: